Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2010 01:40 ET | Source: Evotec AG

Evotec Brings Project in Neuropathic Pain Into Clinical Development in Its Alliance With Boehringer Ingelheim

HAMBURG, Germany, May 19, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that a compound in its strategic alliance with Boehringer Ingelheim has advanced into clinical...
May 12, 2010 01:43 ET | Source: Evotec AG

Evotec's Drug Discovery Business Set for Strong Growth

HAMBURG, Germany, May 12, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the first quarter of 2010. RECENT...
May 10, 2010 01:38 ET | Source: Evotec AG

Evotec Enters Into Integrated Drug Discovery Alliance With Genentech

HAMBURG, Germany, May 10, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a multi-year integrated drug discovery alliance with Genentech Inc., a...
May 05, 2010 10:38 ET | Source: Evotec AG

Evotec to Report First Quarter 2010 Results on 12 May 2010

HAMBURG, Germany, May 5, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) will report its financial results for the first quarter of 2010 on Wednesday, 12 May 2010. The Company is going...
April 27, 2010 02:08 ET | Source: Evotec AG

Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme Into the Clinic

HAMBURG, Germany, April 27, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of...
March 25, 2010 02:51 ET | Source: Evotec AG

Evotec's 2009 Results: Significant Step Towards Sustainability

HAMBURG, Germany, March 25, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the year ended 31 December 2009. Major...
March 23, 2010 05:49 ET | Source: Evotec AG

TVM Capital Portfolio Company, Evotec AG, Named M&A Advisor Global Healthcare Turnaround Company of the Year

HAMBURG, Germany, March 23, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) has been named the M&A Advisor Healthcare Turnaround Company of the Year for the development and...
March 11, 2010 02:05 ET | Source: Evotec AG

Evotec Signs High Throughput Screening Agreement With Active Biotech

HAMBURG, Germany, March 11, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a collaboration with Active Biotech AB (Stockholm:ACTI) to identify...
March 10, 2010 01:37 ET | Source: Evotec AG

Evotec Reports Good Progress in Product Development in Treatment-Resistant Depression in its Alliance With Roche

Successful completion of first-in-man study with EVT 103 Positive feedback from the FDA to initiate Phase II with EVT 101 HAMBURG, Germany, March 10, 2010 (GLOBE NEWSWIRE) -- Evotec AG...
March 01, 2010 08:05 ET | Source: Evotec AG

Evotec AG: Fiscal Year 2009 Results Presentation on 25 March 2010 Live on the Internet

HAMBURG, Germany, March 1, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) is going to broadcast its press & analyst conference in Frankfurt live on the internet. The Management Board...